Home / Blog / seeBOOST Electronic Glasses Improve Central Vision: Interview with CEO Patrick Antaki

seeBOOST Electronic Glasses Improve Central Vision: Interview with CEO Patrick Antaki

seeBOOST Electronic Glasses Improve Central Vision: Interview with CEO Patrick Antaki

Central imaginative and prescient loss is a devastating complication of illnesses equivalent to diabetes and macular degeneration. Because central imaginative and prescient is liable for visible acuity, lack of it could critically have an effect on one’s independence and total interplay with the arena.

seeBOOST is a couple of prescription glasses that enhance central imaginative and prescient. The instrument is composed of prescription eyeglasses with a light-weight digital display screen fastened onto one lens. The display screen presentations a magnified and vibrant video symbol of the arena. The instrument has computerized distinction enhancement and adjustable magnification from 1.Four-Eight.0x, and the monocular design implies that the wearer can nonetheless have interaction naturally inside of conversations.

We requested Co-Founder
and CEO Patrick Antaki extra about seeBOOST.

Cici Zhou, Medgadget: Tell
me about how seeBOOST began. What used to be the muse at the back of the theory and
product?

Patrick Antaki, seeBOOST: The founders of seeBOOST have blended greater than 40 years of revel in within the house of head fastened presentations for business, army and shopper packages. In 2012, they become acutely aware of the analysis paintings of Dr. Robert Massoff at Johns Hopkins University, which demonstrated the effectiveness of head-worn digital presentations with magnification and distinction enhancement in making improvements to the sight of sufferers with central imaginative and prescient loss.

Dr. Massoff used a big, cumbersome head-worn helmet device which used to be now not
sensible for prolonged use via sufferers of their on a regular basis lives.  Our
founders known that via making use of their abilities and data they may
create a light-weight, head-mounted device that may be used for prolonged
classes of time and be offering stepped forward high quality of existence to these impacted via sight
loss because of age-related macular degeneration or diabetic macular edema.

Medgadget: How
does the generation paintings, and does it take time for sufferers to conform?

Antaki: seeBOOST works via bettering the picture of regardless of the wearer is taking a look at with each variable magnification and distinction enhancement.  The instrument provides rapid autofocus and imperceptible symbol latency which enhance person revel in and avoids sensory mismatch which might lead to discomfort or nausea. The small measurement leaves the peripheral imaginative and prescient box unobstructed for much more herbal connection with the person’s setting.

Medgadget:
At what level is the corporate nowadays? (Number of staff participants, level of
building and use, funding investment, and so forth.)

Antaki: seeBOOST has 4 energetic staff participants: founders Pat Antaki, Ronnie Dunn, and Russ Lemberg, and President Don Dias.  We have advanced and manufactured our Generation 1 instrument, which has stepped forward the lives of over 150 folks troubled with vital imaginative and prescient loss. We are in energetic building of our Generation 2 type which provides many vital efficiency, convenience, and aesthetic enhancements. To date we’ve got raised simply over $three million from seed and angel buyers. We are these days in search of buyers to fund the advance and marketplace release of the Generation 2 type.

Medgadget: What
are one of the crucial largest demanding situations going through the staff over the following couple of years?

Antaki: Creating the optimum gross sales channel is the most important problem. People with serious central imaginative and prescient loss are underserved via the scientific group, specifically on the subject of units which is able to be offering them stepped forward high quality of existence.

Product web page: seeBOOST

(serve as(d, s, identity)
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(identity)) go back;
js = d.createElement(s); js.identity = identity;
js.src = “http://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.4&appId=2624537092”;
fjs.parentNode.insertBefore(js, fjs);
(report, ‘script’, ‘facebook-jssdk’));

Check Also

Guidelines on Delaying Cancer Surgery During COVID-19

Guidelines on Delaying Cancer Surgery During COVID-19 What your physician is studying on Medscape.com: …

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: